tobanum

Known as: chloranolol, Cloranolol, 2-propanol, 1-(2,5-dichlorophenoxy)-3-((1,1-dimethylethyl)amino)- 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-1995
012319801995

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1991
1991
The antiarrhythmic effects and pharmacodynamics of tobanum were evaluated in 28 patients wist paroxysms of reciprocal… (More)
Is this relevant?
1990
1990
The authors examined the effect of beta-blocker monotherapy (Tobanum tab = 5 mg cloranololum hydrochloricum) and beta-blocker… (More)
Is this relevant?
1989
1989
Three nonselective beta-adrenoceptor blockers, propranolol, cloranolol and talinolol, were examined in male rats. The amount and… (More)
Is this relevant?
1986
1986
The antihypertensive effect and tolerance of chlorpropanol was determined in 30 patients with hypertonic disease. The treatment… (More)
Is this relevant?
1986
1986
A clinical study of the efficiency of a new beta-blocker, chloranolol (Tobanum, Hungary), was carried out in 24 patients with… (More)
Is this relevant?
1984
1984
Chloranolol (5 mg/kg i.p.) retarded the disappearance of noradrenaline induced by the dopamine-beta-hydroxylase (DBH) inhibitor… (More)
Is this relevant?
1981
1981
Quantitative gas--liquid chromatographic (GLC) and GLC--mass spectrometric (MS) methods for the determination of Tobanum, a new… (More)
Is this relevant?
1980
1980
The compound GYKI-41 099, as a beta-adrenergic antagonist, is 3-8 times more potent than propranolol in vitro and in vivo. Its… (More)
Is this relevant?
1980
1980
The electrophysiological properties of Tobanum (a new beta receptor blocking drug) were studied in 14 patients by the aid of His… (More)
Is this relevant?
1980
1980
The acute and chronic circulatory effects of a new beta adrenergic blocking drug, dl-1-(2,5-dichlorophenoxy)-3-tertiary… (More)
Is this relevant?